- Display 15 Products per page
Published: April 1, 2008 | Price: $500.00 – $3,990.00
Lagging FDA approvals led to a brief absence of Rx to OTC switches in the pharmaceutical marketplace, but 2006 and 2007 saw a number of switches, and Kalorama Information believes this product management tactic will continue to be aggressively utilized as companies seek ways to extend revenue life. Kalorama Information's The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies contians a complete overview of the US market for prescription drugs likely to switch in the...Published: July 1, 2008 | Price: $500.00 – $7,000.00
Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich nations will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. Kalorama's Pharmaceutical Markets in Brazil, Russia, India and China (BRIC nations) takes a...Published: April 1, 2009 | Price: $500.00 – $3,990.00
Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what aspects of healthcare will be impacted? How much of spending will be out of the consumer's pocket? How will some novel trends (retail clinics, medical tourism) fit into this economy? It is commonly asserted that OTC and generic drugs sales will be boosted. Will this pan out? What will be the possible...Published: May 1, 2010 | Price: $500.00 – $2,400.00
The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths. Who were the companies that performed best in this market? How did goverment contracts play out? Most importantly, what are lessons for future pandemic and...Published: December 4, 2012 | Price: $500.00 – $1,000.00
This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. Several cancers are being treated with these newer therapies, which provide a focus of cancer profiled in this report, including: Breast Colorectal Head/Neck Kidney Leukemia Liver Lung Melanoma Ovarian Pancreatic Prostate Stomach The report covers both currently marketed and late stage development kinase inhibitors for cancer treatment. Revenues for this market segment were generated using dollar...Published: April 7, 2014 | Price: $500.00 – $1,000.00
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered look at the pharmaceutical industry, including the late-term pipeline of major companies. This report provides long-term company sales forecasts based recent market conditions. For each company, the report provides: Revenues R&D Spending Geographic Breakout of Revenues Performance of Specific Products Performance by Drug Category Late-Stage Pipeline Projections of Revenues to 2023 In addition...Published: January 12, 2015 | Price: $500.00 – $1,000.00
Abbott Diagnostics: Company Profile Abbott Diagnostics: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Abbott Diagnostics. Abbott Laboratories is a global leader in the IVD industry, a global, diversified health care company active in pharmaceuticals, nutritionals, devices and diagnostics. Abbott's diagnostic products’ strength lies in their sheer presence worldwide. The company...Published: January 21, 2015 | Price: $500.00 – $1,000.00
Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Roche Diagnostics. Roche is the world's largest supplier of clinical diagnostics products, the world leader in IVD and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic...Published: January 21, 2015 | Price: $500.00 – $1,000.00
Siemens Healthcare: Company Profile Siemens Healthcare: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Siemens Healthcare. Siemens Healthcare offers a comprehensive portfolio of medical solutions across the treatment chain – from prevention and early detection to diagnosis, treatment and follow-up care. Siemens is a major supplier of technology to the healthcare...Published: February 17, 2015 | Price: $500.00 – $1,000.00
IVD Mergers and Acquisitions Kalorama Information continously tracks mergers and acquisitons in the IVD market. This report IVD Mergers and Acquisitions, records and details 130 significant acquisitions that have taken place from 2012 to early 2015. Companies are the future of the industry lies in the development of more accurate, faster, usable devices. It also involves devices that are IT capable. It’s impossible for eve the largest companies to own all of the innovative technology, so M&A is an important...Published: March 3, 2015 | Price: $500.00 – $7,990.00
Retail Clinics 2015: Growth of Stores, Consumer Opinion, Leading Competitors, Sales of Products to Clinics (Diagnostic Tests, Pharmaceuticals, Vaccines), Clinic Sales Forecasts and Trends Retail health clinics are a fast-growing and unique segment of the U.S. health care system. A concept less than two decades old, retail clinics are typically located in drug store, mass retailers or grocery stores for maximum convenience to the users. They offer low cost services, accept insuracne, staff with nurses or nurse practitioners and have...Published: May 8, 2015 | Price: $500.00 – $3,000.00
The Global Market for Medical Devices, 6th Edition The publication of the sixth edition of Kalorama Information’s Global Market for Medical Devices coincides with a number of changes in the medical device market. A major merger between Medtronic and Covidien has changed market share position, and that merger was not unique. Companies in the device market are merging to build revenue growth and present combined offerings to hospital and physician customers. In Europe as well as the United States, reimbursement...Published: November 16, 2018 | Price: $500.00 – $1,000.00
Smartphone-Based IVD: Products, Trends, Potential Markets The techniques that can most successfully harness mobile phone technology look to be lateral flow immunoassay-based tests, ELISAs, and spectrophotometry, as they are methodologies that use a tool that has become ubiquitous in the developed world and is on the rise globally, the smartphone camera. In recent years, researchers have been developing algorithms and machine learning systems that can scan and analyze colorimetric tests as accurately as a sophisticated piece of laboratory machinery, but...Published: February 1, 2003 | Price: $596.00 – $1,192.00
To succeed in the diagnostics market of the 21st Century, a company has to have either a strong niche position in a particular market segment or be a jack of all trades. In either case, a full or comprehensive menu is critical. Why reinvent the wheel? Most tests and systems are already available somewhere, offered by reputable companies with a strong R&D background. This report is designed to provide a window on IVD market and product opportunities available outside North...Published: April 16, 2014 | Price: $600.00 – $1,200.00
Results of the 2014 (Jan-Feb 2014) survey of glucose meter users.